Bottom line
Is BINV a good fund? The bottom line
BINV is a managed international stock ETF from Transamerica.
It charges 0.7% — about $70 a year on every $10,000 invested, cheaper than 71% of international stock funds we track.
It returned +37.6% over one year (as of Dec 31, 2025, per its prospectus).
With $490 million in net assets and 67 holdings, its largest position is Sanofi Sa (3.1%) and the top 10 make up 23% of the portfolio.
Updated Nov 19, 2026
What BINV invests in
The Brandes International ETF (the Fund) seeks long term capital appreciation.
The Fund is an actively managed exchange-traded fund (ETF) that seeks to attain its investment objective by investing primarily in equity securities of foreign companies. The types of equity securities in which the Fund invests are common and preferred stocks, American Depositary Receipts (ADRs), and warrants and rights. The Fund typically invests in foreign companies with market capitalizations (market value of publicly traded equity securities) greater than $5 billion at the time of purchase. A foreign company is determined to be foreign on the basis of its domicile being outside the U.S., its principal place of business being outside the U.S., its primary stock exchange listing being outside the U.S., and/or at least 50% of its revenues being derived from goods sold or produced, investments made, or services performed outside the U.S. Under normal market conditions, the Fund will…
From the fund's prospectus (filed Oct 28, 2026).
BINV performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| BINV | +37.6% | — | — |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What BINV costs
On a $10,000 investment, BINV's 0.7% expense ratio costs about $70 a year. The prospectus estimates $871 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
BINV top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Sanofi Sa SAN | 3.10% |
| 2 | Sap Se SAP | 2.58% |
| 3 | Takeda Pharmaceutical Company Ltd 4502 | 2.35% |
| 4 | Alibaba Group Holding Ltd BABA | 2.34% |
| 5 | Henkel Ag & Co. Kgaa HEN | 2.33% |
| 6 | Wal-mart De Mexico Sab De Cv (wal-mart De Mexico Sa De Cv) WALMEX* | 2.29% |
| 7 | Compagnie Financiere Richemont Sa CFR | 2.10% |
| 8 | Heineken Holding Nv HEIO | 2.06% |
| 9 | Reckitt Benckiser Group Plc | 1.92% |
| 10 | Dsm Firmenich Ag DSFIR | 1.91% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 23% of the fund. See all top 25 holdings and asset mix →